Phase III randomised controlled trial (RCT) comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer (CompARE).

Hisham M. Mehanna,M. Sen,John D. Chester,Paul Sanghera,Vinidh Paleri,Piers Gaunt,Jaspreet Babrah,Andrew Hartley,Anthony Kong,H. Al-Booz,Bernadette Foran,Elizabeth Miles,Max Robinson,Marcus Jepson,Jenny Donnovan,Christina Yap,Charlotte M. Firth,Claire Gaunt,Sarah Bowden,Martin Forster

Phase III randomised controlled trial (RCT) comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer (CompARE).

2017

TPS6091Background: Patients with intermediate and high-risk oropharyngeal cancer (OPC) have poorer response to standard treatment and poorer overall survival compared to low-risk OPC. The CompARE t...

Keywords:

Randomized controlled trial
Physical therapy
Cancer
Medicine
Standard treatment
Oncology
Internal medicine
overall survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations